{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:11:36Z","timestamp":1791321096238,"version":"4.3.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2007,6,13]],"date-time":"2007-06-13T00:00:00Z","timestamp":1181692800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2007,9,19]]},"DOI":"10.1245\/s10434-007-9464-y","type":"journal-article","created":{"date-parts":[[2007,6,12]],"date-time":"2007-06-12T15:14:48Z","timestamp":1181661288000},"page":"2721-2729","source":"Crossref","is-referenced-by-count":88,"title":["Expression of Human Leukocyte Antigen G (HLA-G) Correlates with Poor Prognosis in Gastric Carcinoma"],"prefix":"10.1245","volume":"14","author":[{"given":"Shang-mian","family":"Yie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shang-rong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan-dan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-mei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,6,13]]},"reference":[{"key":"9464_CR1","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1146\/annurev.iy.06.040188.002043","volume":"6","author":"K Tanaka","year":"1988","unstructured":"Tanaka K, Yoshioka T, Bieberich C, et al. Role of the major histocompatibility complex class I antigens in tumor growth and metastasis. Ann Rev Immunol 1988; 6:359\u201380","journal-title":"Ann Rev Immunol"},{"key":"9464_CR2","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0167-5699(95)80033-6","volume":"16","author":"S Ferrone","year":"1995","unstructured":"Ferrone S, Marincola FM. Loss of HLA class I antigens by melanoma cells: molecular mechanism, functional significance and clinical relevance. Immunol Today 1995; 16:487\u201394","journal-title":"Immunol Today"},{"key":"9464_CR3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0167-5699(96)10075-X","volume":"18","author":"F Garrido","year":"1997","unstructured":"Garrido F, Ruiz-Cabello F, Cabrera T, et al. Implications for immunosurveillance of altered HLA class I phenotypes in human tumours. Immunol Today 1997; 18:89\u201395","journal-title":"Immunol Today"},{"key":"9464_CR4","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S1357-4310(99)01451-3","volume":"5","author":"DJ Hicklin","year":"1999","unstructured":"Hicklin DJ, Marincola FM, Ferrone S. HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story. Mol Med Today 1999; 5:178\u201386","journal-title":"Mol Med Today"},{"key":"9464_CR5","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S1471-4906(02)00039-X","volume":"24","author":"B Seliger","year":"2003","unstructured":"Seliger B, Abken H, Ferrone S. HLA-G and MIC expression in tumors and their role in anti-tumor immunity. TRENDS in Immunol 2003; 24:82\u20137","journal-title":"TRENDS in Immunol"},{"key":"9464_CR6","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1034\/j.1399-0039.2003.00143.x","volume":"62","author":"J LeMaoult","year":"2003","unstructured":"LeMaoult J, Le Discorde M, Rouas-Freiss N, et al. Biology and functions of human leukocyte antigen-G in health and sickness. Tissue Antigens 2003: 62: 273\u201384","journal-title":"Tissue Antigens"},{"key":"9464_CR7","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1097\/00000478-200207000-00010","volume":"26","author":"G Singer","year":"2002","unstructured":"Singer G, Kurman RJ, McMaster MT, et al. HLA-G immunoreactivity is specific for intermediate trophoblast in gestational trophoblastic disease and can serve as a useful marker in differential diagnosis. Am J Surg Pathol 2002; 26:914\u201320","journal-title":"Am J Surg Pathol"},{"key":"9464_CR8","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/ijc.11456","volume":"108","author":"EC Ibrahim","year":"2004","unstructured":"Ibrahim EC, Aractingi S, Allory Y, et al. Analysis of HLA antigen expression in benign and malignant melanocytic lesions reveals that upregulation of HLA-G expression correlates with malignant transformation, high inflammatory infiltration and HLA-A1 genotype. Int J Cancer 2004; 108:243\u201350","journal-title":"Int J Cancer"},{"key":"9464_CR9","first-page":"4107","volume":"63","author":"J Bukur","year":"2003","unstructured":"Bukur J, Rebmann V, Grosse-Wilde H, et al. Functional role of human leukocyte antigen-G up-regulation in renal cell carcinoma. Cancer Res 2003; 63:4107\u201311","journal-title":"Cancer Res"},{"key":"9464_CR10","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0002-9440(10)61756-7","volume":"159","author":"M Urosevic","year":"2001","unstructured":"Urosevic M, Kurrer MO, Kamarashev J, et al. Human leukocyte antigen G up-regulation in lung cancer associates with high-grade human histology, leukocyte antigen class I loss and interleukin-10 production. Am J Pathol 2001; 159:817\u201324","journal-title":"Am J Pathol"},{"key":"9464_CR11","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/path.1039","volume":"196","author":"S Lefebvre","year":"2002","unstructured":"Lefebvre S, Antoinc M, Uzan S, et al. Specific activation of the non-classical class I histocompatibility HLA-G antigen and expression of the ILT2 inhibitory receptor in human breast cancer. J Pathol 2002; 196:266\u201374","journal-title":"J Pathol"},{"key":"9464_CR12","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1182\/blood.V99.2.609","volume":"99","author":"M Urosevic","year":"2002","unstructured":"Urosevic M, Willers J, Mueller B, et al. HLA-G protein up-regulation in primary cutaneous lymphomas is associated with interleukin-10 expression in large cell T-cell lymphomas and indolent B-cell lymphomas. Blood 2002; 99:609\u201317","journal-title":"Blood"},{"key":"9464_CR13","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ygyno.2004.09.049","volume":"96","author":"B Davidson","year":"2005","unstructured":"Davidson B, Elstrand MB, McMaster MT, et al. HLA-G expression in effusions is a possible marker of tumor susceptibility to chemotherapy in ovarian carcinoma. Gynecol Oncol 2005; 96:42\u20137","journal-title":"Gynecol Oncol"},{"key":"9464_CR14","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ygyno.2006.01.045","volume":"103","author":"BF Barrier","year":"2006","unstructured":"Barrier BF, Kendall BS, Sharpe-Timms K, et al. Characterization of human leukocyte antigen-G (HLA-G) expression in endometrial adenocarcinoma. Gynecol Oncol 2006; 103:25\u201330","journal-title":"Gynecol Oncol"},{"key":"9464_CR15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1385\/IJGC:35:1:015","volume":"35","author":"DE Hansel","year":"2005","unstructured":"Hansel DE, Rahmanb A, Wilentz RE, et al. HLA-G upregulation in pre-malignant and malignant lesions of the gastrointestinal tract Int J Gastrointest Cancer 2005; 35:15\u201324","journal-title":"Int J Gastrointest Cancer"},{"key":"9464_CR16","first-page":"349","volume":"2","author":"Y Fukushima","year":"1998","unstructured":"Fukushima Y, Oshika Y, Nakamura M, et al. Increased expression of human histocompatibility leukocyte antigen-G in colorectal cancer cells. Int J Mo Med 1998; 2:349\u201351","journal-title":"Int J Mo Med"},{"key":"9464_CR17","unstructured":"Ishigami S, Natsugoe S, Miyazono F, et al. HLA-G expression in gastric cancer. Anticancer Res 2006: 2467\u201372"},{"key":"9464_CR18","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0065-2776(03)81006-4","volume":"81","author":"ED Carosella","year":"2003","unstructured":"Carosella ED, Moreau P, Le Maoult J, Le Discorde M, Dausset J, Rouas-Freiss N. HLA-G molecules: from maternal-fetal tolerance to tissue acceptance. Adv Immunol 2003; 81:199\u2013252","journal-title":"Adv Immunol"},{"key":"9464_CR19","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.humimm.2003.08.346","volume":"64","author":"M Le Discorde","year":"2003","unstructured":"Le Discorde M, Moreau P, Sabatier P, et al. Expression of HLA-G in human cornea, an immune-privileged tissue. Hum Immunol 2003; 64:1039\u201344","journal-title":"Hum Immunol"},{"key":"9464_CR20","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/j.0022-202X.2005.23927.x","volume":"125","author":"T Ito","year":"2005","unstructured":"Ito T, Ito N, Saathoff M, et al. Immunology of the human nail apparatus: the nail matrix is a site of relative immune privilege. J Invest Dermatol 2005; 125:1139\u201348","journal-title":"J Invest Dermatol"},{"key":"9464_CR21","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.2337\/db05-0731","volume":"55","author":"V Cirulli","year":"2006","unstructured":"Cirulli V, Zalatan J, McMaster M, et al. The class I HLA repertoire of pancreatic islets comprises the nonclassical class Ib antigen HLA-G. Diabetes 2006; 55:1214\u201322","journal-title":"Diabetes"},{"key":"9464_CR22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0165-0378(00)00070-X","volume":"48","author":"DR Bainbridge","year":"2000","unstructured":"Bainbridge DR, Ellis SA, Sargent IL. HLA-G suppresses proliferation of CD4 (+) T-lymphocytes. J Reprod Immunol 2000; 48:17\u201326","journal-title":"J Reprod Immunol"},{"key":"9464_CR23","doi-asserted-by":"crossref","first-page":"12150","DOI":"10.1073\/pnas.201407398","volume":"98","author":"N Lila","year":"2001","unstructured":"Lila N, Rouas-Freiss N, Dausset J, et al. Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: a CD4+ T cell regulatory mechanism. Proc Natl Acad Sci USA 2001; 98:12150\u20135","journal-title":"Proc Natl Acad Sci USA"},{"key":"9464_CR24","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1093\/intimm\/11.8.1351","volume":"11","author":"FA Le Gal","year":"1999","unstructured":"Le Gal FA, Riteau B, Sedlik C, et al. HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes. Int Immunol 1999; 11:1351\u20136","journal-title":"Int Immunol"},{"key":"9464_CR25","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/intimm\/13.2.193","volume":"13","author":"B Riteau","year":"2001","unstructured":"Riteau B, Menier C, Khalil-Daher I, et al. HLA-G1 co-expression boosts the HLA class I-mediated NK lysis inhibition. Int Immunol 2001; 13:193\u2013201","journal-title":"Int Immunol"},{"key":"9464_CR26","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S1044-579X(03)00028-2","volume":"13","author":"V Rebmann","year":"2003","unstructured":"Rebmann V, Regel J, Stolke D, et al. Secretion of sHLA-G molecules in malignancies. Semin Cancer Biol 2003; 13:371\u20137","journal-title":"Semin Cancer Biol"},{"key":"9464_CR27","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.humimm.2003.08.345","volume":"64","author":"Y Sebti","year":"2003","unstructured":"Sebti Y, Le Friec G, Pangault C, et al. Soluble HLA-G molecules are increased in lymphoproliferative disorders. Hum Immunol 2003; 64:1093\u2013101","journal-title":"Hum Immunol"},{"key":"9464_CR28","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1182\/blood-2004-08-3335","volume":"105","author":"H Nuckel","year":"2005","unstructured":"Nuckel H, Rebmann V, Durig J, et al. HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemia. Blood 2005; 105:1694\u20138","journal-title":"Blood"},{"key":"9464_CR29","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/1097-0142(20010715)92:2<369::AID-CNCR1332>3.0.CO;2-U","volume":"92","author":"S Ugurel","year":"2001","unstructured":"Ugurel S, Rebmann V, Ferrone S, et al. Soluble human leukocyte antigen-G serum level is elevated in melanoma patients and is further increased by interferon-alpha immunotherapy. Cancer 2001; 92:369\u201376","journal-title":"Cancer"},{"key":"9464_CR30","first-page":"4460","volume":"9","author":"G Singer","year":"2003","unstructured":"Singer G, Rebmann V, Chen YC, et al. HLA-G is a potential tumor marker in malignant ascites. Clin Cancer Res 2003; 9:4460\u20134","journal-title":"Clin Cancer Res"},{"key":"9464_CR31","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/modpathol.3800751","volume":"20","author":"SR Ye","year":"2007","unstructured":"Ye SR, Yang H, Li K, et al. Human leukocyte antigen G (HLA-G) expression: as a significant prognostic indicator for patients with colorectal cancer. Modern Pathol 2007; 20:375\u201383","journal-title":"Modern Pathol"},{"issue":"suppl","key":"9464_CR32","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0959-8049(01)00267-2","volume":"37","author":"DM Parkin","year":"2001","unstructured":"Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000: the global picture. Eur J Cancer 2001; 37(suppl):4\u201366","journal-title":"Eur J Cancer"},{"key":"9464_CR33","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1158\/1055-9965.EPI-04-0680","volume":"14","author":"L Yang","year":"2005","unstructured":"Yang L, Parkin DM, Ferlay J, et al. Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol Biomarkers Prev 2005; 14:243\u201350","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"9464_CR34","first-page":"37","volume-title":"Pathology and Genetics. Tumors of the Digestive System, vol. 1","author":"C Fenogilo-Preiser","year":"2000","unstructured":"Fenogilo-Preiser C, Carneiro F, Correa P, et al. Gastric carcinoma. In: Hamilton S, Aaltonin L (ed.) Pathology and Genetics. Tumors of the Digestive System, vol. 1, Lyon, France: Lyon Press, 2000:37\u201352"},{"key":"9464_CR35","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0198-8859(02)00821-2","volume":"64","author":"C Menier","year":"2003","unstructured":"Menier C, Saez B, Horejsi V, et al. Characterization of monoclonal antibodies recognizing HLA-G or HLA-E: new tools to analyze the expression of nonclassical HLA class I molecules. Hum Immunol 2003; 64:315\u201326","journal-title":"Hum Immunol"},{"key":"9464_CR36","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0002-9440(10)63994-6","volume":"158","author":"J Alexander","year":"2001","unstructured":"Alexander J, Watanabe T, Wu TT, et al. Histopathological identification of colon cancer with microsatellite instability. Am J Pathol 2001; 158:527\u201335","journal-title":"Am J Pathol"},{"key":"9464_CR37","unstructured":"Ferlay J, Bray F, Pisani P, et al. GLOBOCAN 2002: Cancer incidence, mortality and prevalence worldwide. Lyon: IARC Press, Cited April 15, 2005. Available from: URL: http:\/\/wwwdep.iarc.fr\/"},{"key":"9464_CR38","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3748\/wjg.v12.i1.17","volume":"12","author":"L Yang","year":"2006","unstructured":"Yang L. Incidence and mortality of gastric cancer in China. World J Gastroenterol 2006; 12:17\u201320","journal-title":"World J Gastroenterol"},{"key":"9464_CR39","first-page":"755","volume-title":"Pathologic Basis of Disease","author":"J Crawford","year":"1994","unstructured":"Crawford J. The gastrointestinal tract. In: Robbins SLCR, Kumar V, Schoen FJ (ed.) Pathologic Basis of Disease. Philadelphia: WB Saunders Co., 1994:755\u201383"},{"key":"9464_CR40","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000050109","volume":"18","author":"J Pinto-de-sousa","year":"2001","unstructured":"Pinto-de-sousa J, David L, Seixas M, et al. Clinicopathologic profiles and prognosis of gastric carcinoma from the cardia, fundus\/body and antrum. Dig Surg 2001; 18:102\u201310","journal-title":"Dig Surg"},{"key":"9464_CR41","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/cncr.20288","volume":"101","author":"A Jemal","year":"2004","unstructured":"Jemal A, Clegg LX, Ward E, et al. Annual report to the nation on the status of cancer, 1975\u20132001, with a special feature regarding survival. Cancer 2004; 101:3\u201327","journal-title":"Cancer"},{"key":"9464_CR42","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/01.sla.0000149300.28588.23","volume":"241","author":"BJ Dicken","year":"2005","unstructured":"Dicken BJ, Bigam DL, Cass C, Mackey JR, Joy AA, Stewart M, Hamilton SM. Gastric Adenocarcinoma: Review and Considerations for Future Directions. Ann Surg 2005; 241:27\u201339","journal-title":"Ann Surg"},{"key":"9464_CR43","doi-asserted-by":"crossref","first-page":"10139","DOI":"10.1158\/0008-5472.CAN-05-0097","volume":"65","author":"N Rouas-Freiss","year":"2005","unstructured":"Rouas-Freiss N, Philippe Moreau P, et al. HLA-G Proteins in Cancer: Do They Provide Tumor Cells with an Escape Mechanism? Cancer Res 2005; 65:10139\u201344","journal-title":"Cancer Res"},{"key":"9464_CR44","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1172\/JCI0215564","volume":"110","author":"KJ Malmberg","year":"2002","unstructured":"Malmberg KJ, Levitsky V, Norell H, et al. IFN-gamma protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94\/NKG2A-dependent mechanism J Clin Invest 2002; 110:1515\u201323","journal-title":"J Clin Invest"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-007-9464-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-007-9464-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-007-9464-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T02:26:37Z","timestamp":1587608797000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-007-9464-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6,13]]},"references-count":44,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007,9,19]]}},"alternative-id":["9464"],"URL":"https:\/\/doi.org\/10.1245\/s10434-007-9464-y","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6,13]]}}}